Product Name | Cordycepin |
Description |
Nucleoside Antagonist |
Purity | >98% (HPLC); NMR (conforms) |
CAS No. | 73-03-0 |
Molecular Formula | C10H13N5O3 |
Molecular Weight | 251.2 |
Field of Use | Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. |
Storage Temperature | -20ºC |
Shipping Temperature | Shipped Ambient |
Product Type | Antagonist |
Solubility | May be dissolved in DMSO (25 mg/ml) |
Source | Synthetic |
Appearance | White powder |
SMILES | NC1=NC=NC2=C1N=CN2[C@@H]3O[C@H](CO)C[C@H]3O |
InChI | InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1 |
InChIKey | OFEZSBMBBKLLBJ-BAJZRUMYSA-N |
Safety Phrases |
Classification: Not a hazardous substance or mixture. Safety Phrases: S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. |
Cite This Product | Cordycepin (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-576) |
Alternative Names | (2R,3R,5S)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol; 3-deoxyadenosine; NSC 63984 |
Research Areas | Alzheimer's Disease, Cardiovascular System, Cell Signaling, Epigenetics and Nuclear Signaling, Heart, Neurodegeneration, Neuroscience, NFkB Pathway, Nuclear Signaling Pathways |
PubChem ID | 6303 |
Scientific Background | Cordycepin is a neucleoside antagonist that is able to interfere with RNA synthesis (1). Cordyceps have more than 21 clinically approved benefits such as anti-diabetic, anti-tumor, anti-oxidative, immunomodulatory and anti-aging effects (2,3). |
References | 1. Siev M., Weignberg R., Penman S., (1969) J Cell Biol. 41(2): 510-520. 2. Zhang Y., et al. (2018) Onco Targets Ther. 11: 4479. 3. Hardeeps S., Sardul S., Sharma A.K. (2014) 3 Biotech. 4(1): 1-12. |
Reviews
There are no reviews yet.